Holen Sie sich die Stockscreener-App
134.19
0.92%
-1.24
Handel nachbörslich:
133.85
-0.34
-0.25%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ILMN?
Forum
Prognose
Aktiensplit
Illumina Inc Aktie (ILMN) Neueste Nachrichten
Insights Into Illumina (ILMN) Q4: Wall Street Projections for Key Metrics - Yahoo! Finance Canada
Multi-Omics Market Set for Explosive Growth to USD 33.25 Billion - openPR.com
San Diego Zoo’s Frozen Zoo Gets Genomic Boost - 101.5 KGB
Synthetic Biology Market Set for Explosive Growth to USD 67.47 - openPR.com
Mediolanum International Funds Ltd Makes New $914,000 Investment in Illumina, Inc. $ILMN - MarketBeat
Illumina (ILMN) Reports Q4: Everything You Need To Know Ahead Of Earnings - Yahoo Finance
What Catalysts Are Shifting The Illumina (ILMN) Story For 2026 And Beyond - Yahoo Finance
Illumina, Inc. and the San Diego Zoo Wildlife Alliance Partner to Sequence the Frozen Zoo - marketscreener.com
Illumina Partners with San Diego Zoo for Genomic Sequencing of Endangered Species - Intellectia AI
Illumina and the San Diego Zoo Wildlife Alliance partner to sequence the Frozen Zoo®, supporting critical conservation genetics efforts globally - PR Newswire
WCM Investment Management LLC Has $384.17 Million Position in Illumina, Inc. $ILMN - MarketBeat
Bioinformatics Market to Witness Massive Growth by 2033: - openPR.com
Video: UK Festival of Genomics & Biodata 2026 - Illumina
PacBio sells short-read DNA sequencing assets to Illumina for $48.1m - Investing.com Canada
Pacific Biosciences of California Closes $48.1 Million Sale of DNA Sequencing Assets to Illumina - marketscreener.com
PacBio (PACB) Finalizes Asset Sale to Illumina, Secures $48.1 Mi - GuruFocus
Illumina completes acquisition of SomaLogic - marketscreener.com
Illumina buys SomaLogic in bid to expand proteomics reach - The Pharma Letter
ILMN Q4 Earnings Preview: NovaSeq X Momentum Likely to Aid Performance - Yahoo Finance UK
Pacific Biosciences of California Signs Asset Purchase Agreement With Illumina Cambridge - TradingView
Does CMS Backing of TruSight Oncology Recast Illumina’s (ILMN) Clinical Genomics Potential? - simplywall.st
PacBio Completes Sale of Short-Read Sequencing Assets to Illumina for $48.1 Million - Quiver Quantitative
Illumina acquires SomaLogic - Medical Buyer
Thrivent Financial for Lutherans Sells 38,212 Shares of Illumina, Inc. $ILMN - MarketBeat
Exosome Research Market to Witness Stunning Growth 2026-2033 - openPR.com
DNA Sequencing Market Covering Prime Factors and Competitive - openPR.com
Y Intercept Hong Kong Ltd Cuts Stock Position in Illumina, Inc. $ILMN - MarketBeat
Cancer Biopsy Market Set for Rapid Growth and Trend by 2026-2033 - openPR.com
Illumina, Inc. $ILMN Position Trimmed by AE Wealth Management LLC - MarketBeat
Metagenomic Sequencing Market to Reach US$ 9.25 Billion by 2033 - openPR.com
Assessing Illumina (ILMN) Valuation As Shares Rebound But Long Term Returns Remain Under Pressure - Yahoo Finance
Can Illumina Inc stock outperform in a bear marketJuly 2025 PostEarnings & Verified Swing Trading Watchlists - baoquankhu1.vn
Understanding the Setup: (ILMN) and Scalable Risk - Stock Traders Daily
Illumina, Inc. $ILMN Position Reduced by Bank of New York Mellon Corp - MarketBeat
Keybank National Association OH Purchases 60,375 Shares of Illumina, Inc. $ILMN - MarketBeat
Standard BioTools completes sale of SomaLogic to Illumina for $350 million - Investing.com Nigeria
Boulder biotech SomaLogic acquired in deal worth up to $425M - The Business Journals
Standard BioTools Completes Sale of SomaLogic to Illumina - Investing News Network
Illumina completes acquisition of SomaLogic for $350 million - Investing.com
Standard BioTools Inc. Completes $350 Million Sale of SomaLogic to Illumina, Enhancing Financial Position for Growth Strategy - Quiver Quantitative
Illumina (NASDAQ: ILMN) completes $350M SomaLogic proteomics deal - Stock Titan
SomaLogic Partnership Resource Hub - Illumina
Impact Partnership Wealth LLC Makes New $744,000 Investment in Illumina, Inc. $ILMN - MarketBeat
Illumina, Inc. (NASDAQ:ILMN) Given Average Recommendation of "Hold" by Analysts - MarketBeat
The Truth About Illumina Inc.: Is This DNA Giant Still Worth Your Money or Is the Hype Over? - AD HOC NEWS
Illumina (ILMN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Yahoo Finance
New Horizons in Microfluidic Market Booming with Rapid Growth Through 2033 |Agilent Technologies, Inc., Illumina, Inc. - openPR.com
Illumina (ILMN) Projected to Post Quarterly Earnings on Thursday - MarketBeat
Illumina, Inc. $ILMN Shares Sold by Mutual of America Capital Management LLC - MarketBeat
Devyser enters Strategic Supply Agreement with Illumina to offer sequencing instruments and products - TradingView
Retirement Systems of Alabama Sells 7,647 Shares of Illumina, Inc. $ILMN - MarketBeat
Illumina, Inc. $ILMN Shares Sold by Mitsubishi UFJ Trust & Banking Corp - MarketBeat
Canaccord Genuity raises Illumina stock price target to $150 on solid results By Investing.com - Investing.com Australia
The Analyst Verdict: Illumina In The Eyes Of 15 Experts - Benzinga
Microarrays Market Size to Accumulate Around USD 10.72 Billion by 2033, Driven by Expanding Genomics Research and Advanced Diagnostic Adoption – SNS Insider - GlobeNewswire Inc.
Illumina price driven lower by pivotal resistanceForecast today26-01-2026 - Economies.com
Canaccord Genuity raises Illumina stock price target to $150 on solid results - Investing.com Nigeria
Illumina Inc. Stock Underperforms Friday When Compared To Competitors - 富途牛牛
Wealth Enhancement Advisory Services LLC Buys 9,997 Shares of Illumina, Inc. $ILMN - MarketBeat
iA Global Asset Management Inc. Purchases New Position in Illumina, Inc. $ILMN - MarketBeat
9,062 Shares in Illumina, Inc. $ILMN Purchased by Rakuten Investment Management Inc. - MarketBeat
2.19%
9.69%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):